Affiner les résultats

Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer

Viale, G. ; Giobbie-Hurder, A. ; Gusterson, B. A. ; Maiorano, E. ; Mastropasqua, M. G. ; Sonzogni, A. ; Mallon, E. ; Colleoni, M. ; Castiglione-Gertsch, M. ; Regan, M. M. ; Price, K. N. ; Brown, R. W. ; Golouh, R. ; Crivellari, D. ; Karlsson, P. ; Öhlschlegel, C. ; Gelber, R. D. ; Goldhirsch, A. ; Coates, A. S.

In: Annals of Oncology, 2009, vol. 21, no. 2, p. 245-254